FTC Navigating Regulatory Restraints As Bill To Restore Monetary Relief Authority Faces Challenges
Executive Summary
Congressional Republicans and biopharma stakeholders support legislation clarifying the Federal Trade Commission’s authority to assess monetary penalties but argue the House legislation needs guardrails.